Use of percutaneous nephrostomy in malignant ureteric obstruction.
Seventeen patients with malignant disease underwent percutaneous nephrostomy to relieve renal failure secondary to ureteric obstruction. Renal function improved in 88%. The median survival time was 18 weeks and 58% left the primary hospital to return home or to a terminal care hospice. Minor complications occurred in 58%. The use of bilateral nephrostomy tubes conferred no greater benefit than a unilateral tube. Intervention in malignant ureteric obstruction may confer some benefit and should not necessarily be viewed with pessimism.
Chapman
M E
ME
Department of Diagnostic Radiology, Edinburg Royal Infirmary, UK.
Reid
J H
JH
D058186:Acute Kidney Injury / Q000209:etiology / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D009403:Nephrostomy, Percutaneous; D010386:Pelvic Neoplasms / Q000150:complications; D011788:Quality of Life; D012189:Retrospective Studies; D014517:Ureteral Obstruction / Q000209:etiology / Q000601:surgery*